EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy
EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro ("ClearPoint"), a global therapy-enabling company offering precise…
Read the full articleYou might also wanna read
New genetic switch could improve gene therapy for drug-resistant epilepsy
Epilepsy affects more than 50 million people worldwide, making it one of the most common neurological disorders. Although medication helps m
New platform combines precision gene targeting with brain-wide delivery
The platform overcomes a key obstacle to delivering gene therapies throughout the brain.
Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
Conditions : Drug-Resistant Epilepsy; Epilepsy; Epilepsy (Treatment Refractory); Epilepsy Comorbidities; Epilepsy, Drug Resistant; Epilepsy,
AI maps brain surgery targets for epilepsy
A new computational platform pinpointed compact brain targets to help surgeons stop drug-resistant seizures. The post AI maps brain surgery
New-Onset Refractory Status Epilepticus (NORSE) - Part 3
Dr. Adam S. Greenblatt discusses treatment options for patients with NORSE [New-onset refractory status epilepticus]. This podcast is sponso
Stellula Therapeutics entwickelt Gen-Therapie für seltene Form kindlicher Epilepsie
CHARLOTTVILLE / LONDON (IT BOLTWISE) – Ein aus der University of Virginia hervorgegangenes Startup arbeitet an einer Gen-Therapie für eine s
Comments
Sign in to join the conversation.
No comments yet. Be the first.